We studied 39 patients with thromboangiitis obliterans to determine their cellular and humoral immune responses to native human collagen Type I and Type III, which are constituents of blood vessels. Cell-mediated sensitivity to these collagens was measured by an antigen-sensitive thymidine-incorporation assay. The mean stimulation index--the ratio of thymidine incorporation in the presence of antigen to that in its absence--with both Type I and Type III collagens used as antigens was significantly higher in patients with thromboangiitis obliterans than in patients with arteriosclerosis obliterans or in healthy male controls. Lymphocytes from 77 per cent of the patients with thromboangiitis obliterans exhibited cellular sensitivity to human Type I or Type III collagens (or both). Furthermore, in 17 of 39 serum samples from the patients with thromboangiitis obliterans a low but significant level of anticollagen antibody activity was detected, whereas there was no antibody activity in serum samples from controls. These results suggest that there is a distinct etiologic factor in this disease and also raise the possibility of differentiating between thromboangiitis obliterans and arteriosclerosis obliterans by immunologic means.
This article has been cited by other articles:
Ostojic, L., Zelenika, D., Zotz, R.B., Sucker, C., Ostojic, Z., Loncar, R.
(2007). Platelet Receptor HPA-1 Polymorphism of {alpha}IIb{beta}3 and 807 C/T Polymorphism of {alpha}2{beta}1 and Buerger's Disease. ANGIOLOGY
58: 169-174
[Abstract]
Paraskevas, K. I., Liapis, C. D., Briana, D. D., Mikhailidis, D. P.
(2007). Thromboangiitis Obliterans (Buerger's Disease): Searching for a Therapeutic Strategy. ANGIOLOGY
58: 75-84
[Abstract]
Puechal, X., Fiessinger, J.-N.
(2007). Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist. Rheumatology (Oxford)
46: 192-199
[Abstract][Full Text]
Olin, J. W
(2002). Are anticardiolipin antibodies really important in thromboangiitis obliterans (Buerger's disease)?. Vasc Med
7: 257-258
Maslowski, L., McBane, R., Alexewicz, P., Wysokinski, W. E
(2002). Antiphospholipid antibodies in thromboangiitis obliterans. Vasc Med
7: 259-264
[Abstract]
Saha, K., Chabra, N., Gulati, S. M.
(2001). Treatment of Patients with Thromboangiitis Obliterans with Cyclophosphamide. ANGIOLOGY
52: 399-407
[Abstract]
Olin, J. W.
(2000). Thromboangiitis Obliterans (Buerger's Disease). NEJM
343: 864-869
[Full Text]
Zellerman, G. L., Lin, M. T. S., Orengo, I., Rosen, T.
(1998). Chronic Ulcerations in the Upper and Lower Extremities. Arch Dermatol
134: 1019-1024
[Full Text]
Wysokinski, W. E., Kwiatkowska, W., Maslowski, L., Witkiewicz, W., Kowal-Gierczak, B.
(1998). Buerger's Disease in Two Brothers: Iliac Artery Occlusion by Thromboangiitis Obliterans: Case Reports. ANGIOLOGY
49: 409-414
[Abstract]
Hada, M., Sakihama, T., Kamiya, K., Tasaka, K., Ueno, A.
(1993). Cellular and Humoral Immune Responses to Vascular Components in Thromboangiitis Obliterans. ANGIOLOGY
44: 533-540
[Abstract]
Papa, M. Z., Adar, R.
(1992). A Critical Look at Thromboangiitis Obliterans (Buerger's Disease). PERSPECT VASC SURG ENDOVASC THER
5: 1-18
Lie, J.T.
(1987). Thromboangiitis Obliterans (Buerger's Disease) in an Elderly Man After Cessation of Cigarette Smoking A Case Report. ANGIOLOGY
38: 864-867
[Abstract]
